Prana Announces that PBT2 Reduces Cognitive Impairment Caused by Tau Protein Accumulation July 17, 2013August 16, 2022
Alterity Therapeutics Launches ATH434 Phase 2 Clinical Trial for the Treatment of Patients with Multiple System Atrophy in Europe August 25, 2022May 23, 2023